| dc.contributor.author | Yorgancıoğlu, A.A. and Gemicioğlu, B. and Kalaycı, Ö. and Kalyoncu, A.F. and Cingi, C. and Murray, R. and Onorato, G. and Arnavielhe, S. and Bedbrook, A. and Bousquet, J. | |
| dc.description.abstract | mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. Allergic Rhinitis and its impact on asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity MASK-rhinitis (Mobile Airways Sentinel networK), the Phase 3 ARIA initiative, is based on the freely available app. The Allergy Diary is used by people who were informed by physicians, searched the internet, Apple App Store, Google Play. Turkish Validation has been available and currently in use. © 2018, Ankara University. All rights reserved. | |
| dc.contributor.department | Department of Chest Diseases, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey; Department of Chest Diseases, Faculty of Cerrahpaşa Medicine, Istanbul University, Istanbul, Turkey; Division of Pediatric Allergy, Faculty of Medicine, Hacettepe University, Ankara, Turkey; Department of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey; Department of Ear, Nose and Throat Diseases, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey; MedScript, Dundalk, Ireland; MACVIA-France, Fondation Partenariale FMC VIA-LR, Montpellier, France; Kyomed, Montpellier, France; MACVIA-France, Fondation partenariale FMC VIA-LR, INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and public health approaches, Villejuif, France; Université Versailles Sttin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France; Euforea, Brussels, Belgium; Montpellier, France | |
